147 related articles for article (PubMed ID: 34160850)
1. The Liver Retransplantation Risk Score: a prognostic model for survival after adult liver retransplantation.
Brüggenwirth IMA; Werner MJM; Adam R; Polak WG; Karam V; Heneghan MA; Mehrabi A; Klempnauer JL; Paul A; Mirza DF; Pratschke J; Salizzoni M; Cherqui D; Allison M; Soubrane O; Staffa SJ; Zurakowski D; Porte RJ; de Meijer VE;
Transpl Int; 2021 Oct; 34(10):1928-1937. PubMed ID: 34160850
[TBL] [Abstract][Full Text] [Related]
2. Predictive factors for survival and score application in liver retransplantation for hepatitis C recurrence.
Song AT; Sobesky R; Vinaixa C; Dumortier J; Radenne S; Durand F; Calmus Y; Rousseau G; Latournerie M; Feray C; Delvart V; Roche B; Haim-Boukobza S; Roque-Afonso AM; Castaing D; Abdala E; D'Albuquerque LA; Duclos-Vallée JC; Berenguer M; Samuel D
World J Gastroenterol; 2016 May; 22(18):4547-58. PubMed ID: 27182164
[TBL] [Abstract][Full Text] [Related]
3. The Evolution of Redo Liver Transplantation Over 35 Years: Analysis of 654 Consecutive Adult Liver Retransplants at a Single Center.
Kaldas FM; Horwitz JK; Noguchi D; Korayem IM; Markovic D; Ebaid S; Agopian VG; Yersiz H; Saab S; Han SB; El Kabany MM; Choi G; Shetty A; Singh J; Wray C; Barjaktarvic I; Farmer DG; Busuttil RW
Ann Surg; 2023 Sep; 278(3):441-451. PubMed ID: 37389564
[TBL] [Abstract][Full Text] [Related]
4. The UK DCD Risk Score: A new proposal to define futility in donation-after-circulatory-death liver transplantation.
Schlegel A; Kalisvaart M; Scalera I; Laing RW; Mergental H; Mirza DF; Perera T; Isaac J; Dutkowski P; Muiesan P
J Hepatol; 2018 Mar; 68(3):456-464. PubMed ID: 29155020
[TBL] [Abstract][Full Text] [Related]
5. Liver Retransplantation Associated With Kidney Transplantation for End-stage Liver Graft Disease and Renal Insufficiency: A Morbid Procedure on a Unique Subgroup of Patients.
Cauchy F; Vibert E; Cherqui D; Perdigao F; Sepulveda A; Samuel D; Calmus Y; Conti F; Adam R; Soubrane O; Scatton O
Transplantation; 2020 Jul; 104(7):1403-1412. PubMed ID: 31651789
[TBL] [Abstract][Full Text] [Related]
6. Survival benefit of repeat liver transplantation in the United States: a serial MELD analysis by hepatitis C status and donor risk index.
Biggins SW; Gralla J; Dodge JL; Bambha KM; Tong S; Barón AE; Inadomi J; Terrault N; Rosen HR
Am J Transplant; 2014 Nov; 14(11):2588-94. PubMed ID: 25243648
[TBL] [Abstract][Full Text] [Related]
7. Modern Outcomes After Liver Retransplantation: A Single-center Experience.
Connor AA; Saharia A; Mobley CM; Hobeika MJ; Victor DW; Kodali S; Brombosz EW; Graviss EA; Nguyen DT; Moore LW; Gaber AO; Ghobrial RM
Transplantation; 2023 Jul; 107(7):1513-1523. PubMed ID: 36706077
[TBL] [Abstract][Full Text] [Related]
8. Predictive index for long-term survival after retransplantation of the liver in adult recipients: analysis of a 26-year experience in a single center.
Hong JC; Kaldas FM; Kositamongkol P; Petrowsky H; Farmer DG; Markovic D; Hiatt JR; Busuttil RW
Ann Surg; 2011 Sep; 254(3):444-8; discussion 448-9. PubMed ID: 21817890
[TBL] [Abstract][Full Text] [Related]
9. Selected liver grafts from donation after circulatory death can be safely used for retransplantation - a multicenter retrospective study.
van Reeven M; van Leeuwen OB; van der Helm D; Darwish Murad S; van den Berg AP; van Hoek B; Alwayn IPJ; Polak WG; Porte RJ
Transpl Int; 2020 Jun; 33(6):667-674. PubMed ID: 32065433
[TBL] [Abstract][Full Text] [Related]
10. Graft and viral outcomes in retransplantation for hepatitis C virus recurrence and HCV primary liver transplantation: a case-control study.
Martí J; De la Serna S; Crespo G; Forns X; Ferrer J; Fondevila C; Navasa M; Fuster J; García-Valdecasas JC
Clin Transplant; 2014 Jul; 28(7):821-8. PubMed ID: 24806099
[TBL] [Abstract][Full Text] [Related]
11. [Clinical study of causes and outcomes in pediatric liver retransplantation].
Sun C; Dong C; Meng XC; Wang K; Qin H; Han C; Yang Y; Zhang FB; Zheng WP; Song ZL; Li HH; Gao W; Shen ZY
Zhonghua Wai Ke Za Zhi; 2021 May; 59(5):353-358. PubMed ID: 33915625
[No Abstract] [Full Text] [Related]
12. Differences in Early Immunosuppressive Therapy Among Liver Retransplantation Recipients in a National Cohort.
Mezochow AK; Abt PL; Bittermann T
Transplantation; 2021 Aug; 105(8):1800-1807. PubMed ID: 32804798
[TBL] [Abstract][Full Text] [Related]
13. Effects of graft quality on non-urgent liver retransplantation survival: should we avoid high-risk donors?
Marti J; Fuster J; Navasa M; Ferrer J; Rimola A; Pelegrina A; Fondevila C; Garcia-Valdecasas JC
World J Surg; 2012 Dec; 36(12):2914-22. PubMed ID: 22968536
[TBL] [Abstract][Full Text] [Related]
14. Comparison of short- and long-term outcomes after early versus late liver retransplantation: a single-center experience.
Kamei H; Al-Basheer M; Shum J; Bloch M; Wall W; Quan D
J Surg Res; 2013 Dec; 185(2):877-82. PubMed ID: 23953787
[TBL] [Abstract][Full Text] [Related]
15. The BAR Score Predicts and Stratifies Outcomes Following Liver Retransplantation: Insights From a Retrospective Cohort Study.
Krendl FJ; Fodor M; Buch ML; Singh J; Esser H; Cardini B; Resch T; Maglione M; Margreiter C; Schlosser L; Hell T; Schaefer B; Zoller H; Tilg H; Schneeberger S; Oberhuber R
Transpl Int; 2024; 37():12104. PubMed ID: 38304197
[TBL] [Abstract][Full Text] [Related]
16. Optimization of liver grafts in liver retransplantation: a European single-center experience.
Martí J; Charco R; Ferrer J; Calatayud D; Rimola A; Navasa M; Fondevila C; Fuster J; García-Valdecasas JC
Surgery; 2008 Nov; 144(5):762-9. PubMed ID: 19081018
[TBL] [Abstract][Full Text] [Related]
17. Liver retransplantation: Timing is equally important.
Li L; Zhang Y; Xiao F; Qu W; Zhang H; Zhu Z
Medicine (Baltimore); 2023 Sep; 102(37):e35165. PubMed ID: 37713841
[TBL] [Abstract][Full Text] [Related]
18. Early Vs Late Liver Retransplantation: Different Characteristics and Prognostic Factors.
Moon HH; Kim TS; Song S; Shin M; Chung YJ; Lee S; Choi GS; Kim JM; Kwon CHD; Lee SK; Joh J
Transplant Proc; 2018 Nov; 50(9):2668-2674. PubMed ID: 30401374
[TBL] [Abstract][Full Text] [Related]
19. Liver Transplant Survival Index for Patients with Model for End-Stage Liver Disease Score ≥ 35: Modeling Risk and Adjusting Expectations in the Share 35 Era.
Steggerda JA; Kim IK; Todo T; Malinoski D; Klein AS; Bloom MB
J Am Coll Surg; 2019 Apr; 228(4):437-450.e8. PubMed ID: 30594593
[TBL] [Abstract][Full Text] [Related]
20. Good outcomes after repeated pediatric liver retransplantations: A justified procedure even in times of organ shortage.
Junger H; Knoppke B; Schurr L; Brennfleck FW; Grothues D; Melter M; Geissler EK; Schlitt HJ; Brunner SM; Goetz M
Pediatr Transplant; 2024 Mar; 28(2):e14699. PubMed ID: 38433343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
